Search results
Results from the WOW.Com Content Network
Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals ...
CPA/EE-containing birth control pills were developed by 1975 [20] [21] and were first introduced for medical use in 1978. [22] They originally contained 50 μg EE (Diane); subsequently, the EE dosage was decreased to 35 μg in a new "low-dose" preparation in 1986 (Diane-35). [4] [23] [24]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The effective dosage of CPA needed to inhibit ovulation by itself in women (i.e., to act as a contraceptive) is 1 mg/day, [1] and the medication is marketed as a contraceptive (combined with low-dose ethinylestradiol) at a dosage of 2 mg/day. [21] [105] [55] For comparison, the ovulation-inhibiting dosage of levonorgestrel is 50 μg/day. [1]
Modified-release dosage and its variants are mechanisms used in tablets (pills) and capsules to dissolve a drug over time in order to be released more slowly and steadily into the bloodstream, while having the advantage of being taken at less frequent intervals than immediate-release (IR) formulations of the same drug.
Naproxen is considered to be the strongest anti-inflammatory medication available over the counter, says Walia. However, this doesn’t mean other OTC anti-inflammatories aren’t just as ...
If you’re 50 or older, you can add up to $7,500 in catch-up contributions in 2024 and 2025 for a total of $30,500 this year and $31,000 next year. ... 55 to 64. $244,750. $87,571. 65 and older ...
Iran has confirmed the arrest of Italian journalist Cecilia Sala, state news agency IRNA said, citing the Iranian Ministry of Culture.